ClinicalTrials.Veeva

Menu

Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income

University of Kansas logo

University of Kansas

Status

Invitation-only

Conditions

Monitoring Blood Pressure
Aspirin Prophylaxis

Treatments

Behavioral: Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07491510
STUDY00160319
1P20GM139733 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this clinical trial is to learn if a telehealth hypertension group prenatal care program (Centering HER / HGPC-T) can improve blood pressure monitoring and aspirin adherence and help reduce early-onset preeclampsia in low-income, predominantly Black pregnant participants in Kansas who are <13 weeks gestation, age ≥18, and moderate or high risk for preeclampsia (USPSTF).

The main question[s] it aims to answer [is/are]:

Does Centering HER increase hypertension monitoring and aspirin compliance compared with usual doula care?

Is Centering HER feasible and acceptable, and what contextual factors influence implementation in community clinics?

Full description

The study will compare Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group sessions with OB/GYN fellow oversight + Bluetooth BP cuff/scale ± Apple Watch) to usual doula care + routine prenatal care to see if the intervention improves monitoring/adherence and supports better BP-related outcomes.

Participants will:

  • Be randomized 2:1 to Centering HER or usual doula care.
  • Complete REDCap surveys at baseline, antepartum, and postpartum.
  • If assigned to Centering HER, attend 7 virtual group sessions and self-monitor/report BP and weight using a Bluetooth BP cuff/scale (± Apple Watch), and keep a medication log if applicable.

Enrollment

36 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • English or Spanish speaking
  • <13 weeks gestations
  • >18 years old
  • moderate or high risk for hypertensive disorders in pregnancy

Exclusion criteria

  • less than18 years of age
  • not receiving prenatal care
  • not eligible for doula care
  • no risk factors for hypertensive disorders in pregnancy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

36 participants in 2 patient groups, including a placebo group

usual doula care + routine prenatal care
Placebo Comparator group
Treatment:
Behavioral: Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group
Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group
Active Comparator group
Description:
routine prenatal care + 7 doula-led 90-minute virtual group sessions with OB/GYN fellow oversight + Bluetooth BP cuff/scale ± Apple Watch
Treatment:
Behavioral: Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems